KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Shares Outstanding (2016 - 2025)

AbbVie (ABBV) has disclosed Shares Outstanding for 13 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding changed 0.17% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, changed 0.17% year-over-year, with the annual reading at $1.8 billion for FY2025, 0.17% changed from the prior year.
  • Shares Outstanding for Q4 2025 was $1.8 billion at AbbVie, down from $1.8 billion in the prior quarter.
  • The five-year high for Shares Outstanding was $1.8 billion in Q3 2025, with the low at $1.8 billion in Q1 2023.
  • Average Shares Outstanding over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2021.
  • The sharpest move saw Shares Outstanding rose 19.57% in 2021, then fell 0.17% in 2023.
  • Over 5 years, Shares Outstanding stood at $1.8 billion in 2021, then rose by 0.06% to $1.8 billion in 2022, then fell by 0.17% to $1.8 billion in 2023, then fell by 0.06% to $1.8 billion in 2024, then increased by 0.17% to $1.8 billion in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $1.8 billion, $1.8 billion, and $1.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.